Authors also found that the development of resistance obtained through EVs carrying PDGFRβ was not just a prerogative of the cell line LM-MEL-64, but also of another melanoma cell line (M229AR) after the exposure to BRAF-inhibitors and linked to resistance [120]. The gene discussed is BRAF; the disease is melanoma.